-+ 0.00%
-+ 0.00%
-+ 0.00%

Jones Trading Downgrades Acrivon Therapeutics to Hold

Benzinga·05/16/2025 20:33:51
Listen to the news
Jones Trading analyst Soumit Roy downgrades Acrivon Therapeutics (NASDAQ:ACRV) from Buy to Hold.